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Engineered intermodular and intramodular polyketide 
synthase fusions 
Robert McDaniel’, Camilla M Kao*, Sue J Hwang* and Chaitan Khosla2t3T4 
Background: Modular polyketide synthases (PKSs) are very large 
multifunctional enzyme complexes that synthesize a number of medicinally 
important natural products. The modular arrangement of active sites has made 
these enzyme systems amenable to combinatorial manipulation for the 
biosynthesis of novel polyketides. Here, we investigate the involvement of 
subunit interactions in hybrid and artificially linked PKSs with several series of 
intermodular and intramodular fusions using the erythromycin 
(6-deoxyerythronolide B synthase; DEBS) and rapamycin (RAPS) PKSs. 
Results: Several two-module and three-module derivatives of DEBS were 
constructed by fusing module 6 to either module 2 or module 3 at varying 
junctions. Polyketide production by these intramodular fusions indicated that 
the core set of active sites remained functional in these hybrid modules, 
although the ketoreductase domain of module 6 was unable to recognize 
unnatural triketide and tetraketide substrates. Artificial trimodular PKS subunits 
were also engineered by covalently linking modules 2 and 3 of DEBS, thereby 
demonstrating the feasibility of constructing single-chain PKSs. Finally, a series 
of fusions containing DEBS and RAPS domains in module 2 of an engineered 
trimodular PKS revealed the structural and functional tolerance for hybrid 
modules created from distinct PKS gene clusters. 
Conclusions: The general success of the intermodular and intramodular 
fusions described here demonstrates significant structural tolerance among 
PKS modules and subunits and suggests that substrate specificity, rather than 
protein-protein interactions, is the primary determinant of molecular recognition 
features of PKSs. Furthermore, the ability to artificially link modules may 
considerably simplify the heterologous expression of modular PKSs in higher 
eukaryotic systems. 
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Introduction 
Polyketides comprise a large and structurally diverse 
family of natural products that display a broad range of 
biological activities. Modular polyketide synthases (PKSs) 
are multifunctional enzyme complexes that catalyze the 
biosynthesis of macrocyclic precursors to medicinally 
important compounds, such as erythromycin [1,2], aver- 
mectin [3], FK.506 [4], rapamycin [S], and candicidin [6]. A 
remarkable feature of this class of modular PKSs is the 
clustering of active sites in ‘modules’ that each perform a 
single cycle of condensation and B-ketoreduction in poly- 
ketide biosynthesis. Because these catalytic domains exhi- 
bit significant homology between modules among all gene 
clusters, modular PKSs have become attractive targets for 
genetic manipulation to produce novel polyketides with 
useful therapeutic activities [7,8]. 
IJsing the erythromycin PKS, 6-deoxyerythronolide B 
synthase (DEBS, Figure l), as a model system, a variety 
of mutagenesis strategies have already demonstrated the 
feasibility of altering the catalytic properties of modular 
PKSs. These include the inactivation of reductive domains 
to bypass B-keto processing steps [2,9,10], deletion of 
modules to manipulate chain length [l l-141, substitution 
of acyltransferase (AT) domains to alter starter [15] and 
extender unit incorporation [16], and addition of reduc- 
tive/dehydrative domains to modules which naturally lack 
these activities [17]. Although these engineered mutants 
have illustrated the tolerance towards unnatural substrates 
by the enzymes of modular PKSs, few experiments have 
systematically addressed the presumed necessity for active- 
site domains and modules in hybrid systems to fold and 
associate correctly with upstream and downstream modules. 
In an attempt to uncover any structural and association 
requirements for hybrid PKSs, we constructed a series of 
PKS mutants with varying intermodular and intramodu- 
lar fusion boundaries. The biosynthesis of polyketides 
from these engineered PKSs, which include the fusions 
between KS and AT (KS: ketosynthase), AT and DH 
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The erythromycin (6-deoxyerythronolide B 
synthase; DEBS) polyketide synthase 
(PKS) which catalyzes the biosynthesis of 
6-deoxyerythronolide B (bdEB, 1). DEBS 
consists of three large multifunctional proteins 
and includes six modules as well as a primer- 
loading segment and a product-release 
segment [1,2]. Each module catalyzes one 
cycle of chain extension and associated 
S-ketoreduction for the biosynthesis of 
6-dEB. All modules include ketosynthase 
(KS), acyltransferase (AT), and acyl carrier 
protein (ACP) domains, which are responsible 
for the assembly of the carbon chain from 
propionyl and methylmalonyl coenzyme A. The 
modules also possess reductive segments 
comprising all, some, or none of the set of 
ketoreductase (KR), dehydratase (DH), and 
enoylreductase (ER) domains, which act on 
the j3-carbonyl following each condensation 
reaction. The loading segment consists of 
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priming AT and ACP domains, whereas a of the PK.9 (The relative sizes of the domains 
thioesterase (TE) forms the release segment are not shown to scale.) 
(DH: dehydratase), and between AT and KR (KR: keto- 
reductase) domains, as well as the covalent linking of 
modules to generate larger PKS subunits, demonstrates 
general flexibility in engineering hybrid PKS modules 
while retaining intact enzyme structure and function. 
These results have important implications for the engi- 
neering of hybrid enzyme systems from two or more 
different modular PKSs to generate new enzymatic path- 
ways that synthesize novel polyketide products. At the 
same time, the ability to construct functional single 
polypeptide chains from multiple PKS subunits offers 
advantages for engineering these systems in cells where 
multi-gene expression may be challenging (e.g. in plants 
and mammals). 
Results and discussion 
lntramodular DEBS fusions 
One desirable route to new biosynthetic products involves 
fusions of modules from two (or more) distinct PKS path- 
ways. The challenge of such fusions is the transfer of 
an intermediate across a pathway junction; this requires 
that the active-site domains in a hybrid module remain 
structurally intact as well as displaying relaxed substrate 
specificities. In order to explore the structural integrity 
of different hybrid modules, we constructed a series of 
fusions between DEBS modules 2,3 and 6 in which fusion 
boundaries were varied in the terminal module. 
Four derivatives of the two-module DEBS system from 
Streptomyces coelicolor CH999/pCKlZ [13] and five deriva- 
tives of the three-module DEBS system from S. coelicolor 
CH999/pCK13 [14] were constructed for this study (Figures 
2 and 3). Plasmid pKA0260 contains engineered PstI and 
XbaI restriction sites at the conserved boundaries of KR2 
(see Figure 2; [18]), which were used to substitute KR2 
with the corresponding KR5 and KR6 domains to generate 
pKOSOll-54 and pKA0288, respectively. A two-module 
fusion between KS2 and AT6 was also constructed in 
pKAO290, with the beginning of the conserved AT domain 
[ 181 as the heterologous junction. 
Of the three-module mutants, plasmids pKA0223, 
pKA0296, and pKA0’222 are derivatives of pCK13 gener- 
ated by fusions between the AT domain of module 3 and 
the KR domain of module 6 (Figure 3). Fusion junctions 
occur at the beginning of the conserved KR boundary [ 181 
for pKA0223 and pKA0296 (marked by engineered NdeI 
and KpnI sites, respectively) and at the end of the con- 
served AT boundary [18] for pKA0222 (marked by an 
engineered &I site). Plasmid pKA0301 contains a fusion 
between the KS domain of module 3 and the AT domain 
of module 6 at the beginning of the conserved AT bound- 
ary [18] (marked by an engineered BarnHI site). Finally, 
plasmid pKA0306 was constructed by linking module 2 
with module 6 to give a single 3-module polypeptide in 
which ACPZ (ACP: acyl carrier protein) and KS3 are 
joined at the end of the conserved ACP domain [18] 
(marked by an engineered SpeI site). 
S. coelicolor CH999/pKA0260 and pKOSO1 l-54 produced 
the natural triketide lactone 2 (Figure 2) at levels compa- 
rable to S. coeiicolor CH999/pCK12 [13], as determined by 
‘H and 13C nuclear magnetic resonance (NMR) spectro- 
scopy (see Materials and methods section). This result, 
which is the second example of a functional KR substitu- 
tion (after pKOS009-7; see below), indicates that KR5 can 
recognize and process an unnatural substrate that is con- 
siderably shorter than its normal substrate, but which 
presumably has the ‘natural’ functionality and stereo- 
chemistry at the ~1, B, and y positions. In contrast, both 
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Bimodular DEBS fusions and triketide products. Substitution of the 
KR2 domain with KR5 (pKOSO1 l-54) leads to the same reduced 
triketide lactone (2) produced by the parent F’KS constructs (pCK12 
and pKAO260). The KR6 domain, however, is unable to catalyze 
5-ketoreduction, either as a single-domain substitution (pKAO288) or 
as a fusion product in module 6 (pKAO290), and results in the 
formation of the unreduced triketide lactone (3). For pKOSO1 l-54, 
pKAO228, and pKAO290, shaded regions correspond to native 
sequence and unshaded regions are substituted or fused domains. 
CH999/pKA0288 and pKA0290 produced the triketide 
ketolactone 3, as determined by lH and t3C NMR spec- 
troscopy (-20 mg/l; see Materials and methods section; 
Figure 2). This product, which has been previously char- 
acterized [19], is derived from a module 2 intermediate 
with an unreduced B-carbonyl. Although this result 
demonstrates that KR6 is nonfunctional in module 2, the 
pKOSOll-54 mutant suggests that this KR6 behavior is 
most likely to arise from stringent specificity towards 
unnatural substrates rather than from a perturbed KR6 
structure. 
Fusions between modules 3 and 6 were selected because of 
their substrate resemblance in a-, B-, and y-carbon function- 
ality and stereochemistry (see Figure 1). The recombinant 
strains S. coe/ico/or CH999/pKA0223, pKA0296, pKAO222, 
and pKAO301 (Figure 3) all produced -10-20 mg/l of the 
tetraketides 4 and 5, as determined by ‘H NMR spectro- 
scopy (pKA0222 and pKA0301; see Materials and methods 
section) or thin layer chromatography (TLC; pKA0296; 
see Materials and methods section). Production of these 
molecules indicates that the structure and function of the 
KS, AT and ACP domains remain intact in the hybrid 
modules, while the KR6 domain appears to be inactive 
towards the unreduced B-carbonyl of the module 3 inter- 
mediate. Although any of the engineered restriction sites 
may interfere with KR6 function, given the results with 
the two-module mutants it is likely that KR6 possesses 
stringent substrate specificity. More significantly, the ter- 
minal modules in both pKA0290 and pKA0301 contain 
a native KS in an otherwise completely heterologous 
module, suggesting that the correct association with a pre- 
vious module is dictated by the amino-terminal KS region 
(i.e. KS’2 for the association of module 2 with module 1 
and KS3 for the noncovalent assembly of module 3 with 
module 2). Because trimodule linked systems are func- 
tional (see below), the failure of S. coelicolor CH999/ 
pKA0306 (Figure 3) to produce any detectable products 
probably stems from tight KS6 specificity. 
Artificially linked PKS subunits 
Genetic characterization of several modular PKSs has sug- 
gested remarkable flexibility in the lower and higher order 
structures of these enzymes. Specifically, the number of 
modules in naturally occurring PKSs varies considerably, 
as does the number of modules within a polypeptide 
subunit. For example, DEBS is composed of three two- 
module polypeptide subunits, while the rapamycin PKS 
(RAPS) consists of two four-module subunits and one six- 
module subunit [S]. The spiramycin gene cluster even 
contains single-module subunits [ 1.51. The regions within 
a PKS module that dictate proper subunit assembly and 
chain transfer between noncovalent as well as covalent 
modules remain undefined, although segments of non- 
conserved residues at the amino and carboxyl termini of 
PKS subunits, between covalently joined modules and 
between certain reductive active sites, may participate in 
subunit assembly and chain transfer [ 181. 
In the light of the structural variation observed among natu- 
rally occurring PKSs, we wished to examine how consecu- 
tive modules might be artificially linked and yet retain 
normal catalytic function. For this purpose, we constructed 
two derivatives of the well-characterized three-module PKS 
from S. coelicolor CH999/pCK13 [14], in which DEBS mod- 
ules 2 and 3 were translationally joined to create a single 
three-module PKS subunit. The first recombinant strain, 
S. coa’icolor CH999/pKA0318 (Figure 4), contains a fusion 
between the stop codon of module 2 and the start codon 
of module 3. All of the 117 nonconserved amino acids 
between ACPZ and KS3 are retained, and a diagnostic N/zeI 
restriction site is present at the fusion boundary (Figure 5). 
In the second linked PKS, expressed by 5’. coelico/or CH9991 
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Trimodular DEBS fusions and tetraketide 
products. Functional fusions give rise to the 
tetraketide lactone (4) and the decarboxylated 
hemiketal (5) 1141. Substitution of the KS6 
domain for KS3 leads to an unproductive PKS 
(pKAO306). Shaded regions correspond to 
native sequence; unshaded regions are 
substituted or fused domains. 
pKA0330 (Figure 4), the ACPZ and KS3 boundaries are Both 5’. coelicolor CH999/pKA0318 and pKA0330 pro- 
connected by the intermodule segment originally connect- duced the natural tetraketides 4 and 5 at yields comparable 
ing DEBS modules 5 and 6. In this mutant, all 117 natural to those of S. coelico/or CH999/pCK13 [14], as determined 
residues between ACPZ and KS3 are replaced by the by rH and W NMR spectroscopy. These results show that 
foreign Z-residue segment (Figure 5). the amino and carboxyl termini of PKS subunits are not 
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Intermodular DEBS fusions to create 
artificially linked modules. In plasmid pCKl3, 
modules 1 and 2 exist as a single open 
reading frame (ORF) and module 3 as a 
separate ORF. Translational coupling of 
modules 2 and 3 in plasmids pKAO318 and 
pKAO330 results in a functional single 
trimodular polypeptide that produces the 
tetraketide lactone (4; as in Figure 3) and the 
decarboxylated hemiketal (5; as in Figure 3). 
Shaded regions correspond to the engineered 
intermodule domains. 
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Figure 5 - 
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Nucleotide sequence of DEBS regions involved in intermodule fusions. 
(a) The wide arrows indicate the locations of the engineered Nhel 
sites, which result in the sequence GGCGATGCTAGCACTGAC 
(Nhel site italicized) in the linked PKS (pKAO318). The fusion 
generates a 11 E-residue linker between the conserved boundaries of 
ACP2 and KS3 1181. The sharp arrows denote the engineered Spel 
and Nhel restriction sites used to join ACPP and KS3 with the 
corresponding segment connecting ACP5 and KS6 (pKAO330; see 
below). The DNA sequences spanning the two boundaries are 
TICCTCACTAGTCGGCTC (Spel site italicized) and 
AAGGATGCTAGCGACCCG (Nhel site italicized). (b) The 
construction generates a 25residue linker between ACP2 and KS3. 
One-letter amino acid codes are shown below the DNA sequence. 
required for chain transfer between covalent modules, and 
they generally demonstrate that PKS subunits can be 
covalently linked without apparent loss of activity. The 
idea that covalently linked subunits can be fully active has 
immediate implications for the construction of hetero- 
logous module series through the artificial joining of 
modules from different PKS systems. 
DEBWRAPS hybrid module fusions 
To systematically examine various module hybrids gener- 
ated from two distinct PKS systems, we constructed a 
series of module 2 fusions using DEBS and RAPS. We 
based these experiments on the recently described plasmid 
pKOS009-7 (Figure 6), a three-module derivative of pCK13 
in which KR2 is substituted by the rapDH/KR4 domain 
[ 171. 8. co&olor CH999/pKOS009-7 produces compound 6 
(Figure 6), a tetraketide product derived from a module 2 
intermediate with a trun.r double bond introduced by the 
rapDH/KR4 activity. Because the chemical structure of 
rapamycin suggests that the rapAT domain encodes 
methylmalonyl transferase activity [.5], we reasoned that, in 
the pCK13 scaffold, a hybrid module 2 containing the 
active sites of DEBS module 2 and RAPS module 4 could 
generate only two different intermediates - the wild- 
type B-hydroxyl triketide or the pKOS009-7 B-enoyl tri- 
ketide. Because CH999/pKOS009-7 demonstrated that 
the RAPS DH/KR4 domains and DEBS module 3 can 
process the unnatural as well as the natural triketide sub- 
strates, we could attribute any defects in polyketide catal- 
ysis to incorrect protein folding or association in the 
module fusions, thereby decoupling structural issues from 
substrate-specificity requirements. 
A series of four hybrid fusions containing domains from 
DEBS module 2 and RAPS module 4 were designed. To 
initially bypass potential subunit association problems, 
these hybrids were constructed in the linked three-module 
scaffold using the plasmid pKOSO1 l-46 (Figure 6), a deriv- 
ative of pKA0330 (Figure 4) with engineered restriction 
sites between the module 2 active sites. Substitutions in 
module 2 included rapACP4 (pKOSO1 l-57) rapDH/KR4+ 
ACP4 (pKOSOll-47) rapAT4+DH/KR4 (pKOSO1 l-59). 
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Figure 6 
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Engineered DEBWRAPS hybrid fusions. Hybrids that lack a dehydratase produce 4 and 5; those with dehydratase activity produce 6 (KOS009-7a). 
All active sites in the hybrid fusions remained fully functional. Unshaded regions (except for the TE) refer to rapamycin module 4 domains. 
and rapAT4+DH/KR4+ACP4 (pKOSO1 l-58) (Figure 6). 
The resulting plasmids were introduced into S. co&o/or 
CH999 and screened for polyketide production. 
KS region participates in the productive association of 
adjacent modules. 
Significance 
Both S. coelicolor CH999/pKOSOll-46 and pKOSOll-57 Modular polyketide synthases (PKSs) are multifunctional 
produced the expected compounds 4 and 5 by TLC enzyme complexes that synthesize a number of medici- 
analysis. The ability of rapACP4 to complement ACPZ nally important natural products. With their modular 
in pKOSOll-57 with little or no effect on polyketide pro- arrangement of active sites, the enzymes possess tremen- 
duction is consistent with a previously described fusion dous potential for the generation of novel compound 
between DEBS KR5 and ACP6 domains [13]. The libraries. In this work, we have generated a series of 
recombinant strains S. coelicolor CH999/pKOSOl l-47, hybrid modular PKSs by engineering intermodular and 
pKOSO1 l-58, and pKOSOll-59 all produced the anticipated intramodular fusions between PKS subunits, thereby 
tetraketide 6, as determined by lH NMR spectroscopy, extending the range of structural manipulations of these 
showing that all the catalytic domains in these fusions multifunctional enzymes from the previous active-site 
retain their expected activity. Although the yields for substitution and inactivation experiments. We have 
these strains were -lo-20% of those originally reported shown that the PKS structure and the active-site speci- 
for pKOS009-7 [17], no difference in production levels ficity are flexible enough to allow fusions between 
was observed between the newly engineered constructs. modules from the same or different PKSs, and separate 
Note that the intact PKS function in CH999/pKOSOll- modules can also be linked to generate enlarged PKS sub- 
58, whose module 2 consists primarily (68%) of RAPS units. Although certain active sites appear to possess 
amino acids, is consistent with the results of pKA0290 stringent specificities towards unnatural substrates, most 
and pKAO301, and further supports the notion that the active sites tested in this work suggest that significant 
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tolerance towards unnatural substrates exists in these’ 
enzyme systems. Furthermore, because hybrid modules 
containing only a native ketosynthase domain produc- 
tively interact with neighboring modules in a heterologous 
PKS system, some determinants of modular assembly 
appear to reside in the amino termini of modules. 
Should the facile construction of intermodular and intra- 
modular fusions prove to be a general feature of modu- 
lar PKSs, the task of generating hybrid pathways from 
different PKS systems may be restricted more by sub- 
strate stringency of active sites than by the structural 
limitations imposed by hybrid modules. Indeed, further 
understanding of structure-function relationships under- 
lying PKS molecular recognition will be required to 
explain and overcome the observed specificity differ- 
ences of homologous active-site domains. Our ability to 
artificially link modules should, however, minimize sub- 
unit dissociation problems in these engineered systems; 
this has immediate implications for the construction of 
heterologous module series. Furthermore, single-chain 
PKSs would be more desirable for expression in higher 
eukaryotic organisms such as plants or mammalian cell 
lines. These approaches, in conjunction with other 
emerging technologies in PKS pathway manipulation, 
should provide access to a broad range of polyketide 
structures and pharmacophores that are not currently 
accessible by synthetic methods and may not even be 
present in nature. 
Materials and methods 
Bacterial strains and culture conditions 
S. coelicolor CH999 [20] was used as the host for production of polyke- 
tides from the engineered plasmids. DNA manipulations were performed in 
fscherichia co/i XL1 Blue (Stratagene) using standard culture conditions 
1211. S. coelicolor strains were grown on RPYE agar plates [221. 
Manipulation of DNA and organisms 
Manipulation and transformation of DNA in E. co/i was performed by 
standard procedures 1211. Polymerase chain reaction (PCR) was per- 
formed with Pfu polymerase (Stratagene) under conditions recom- 
mended by the manufacturer. S. coelicolor protoplasts were transformed 
by the standard procedure [22] and transformants were selected using 
2 ml of a 500 pg/ml thiostrepton (Sigma) overlay. 
PCR amplification of active-site domains used for substitutions 
The active site domains used for substitution in plasmids below were PCR 
amplified from plasmids or cosmids containing DEBS (pCK7) 1231 or 
RAPS [171 DNA. The following oligonucleotides containing appropriate 
flanking restriction sites (shown in italics) for substitution were used: 
eryKR5, forward 5’-TTTCTGCAGATCCCCACCGGCGGGCGCGCA-3 
and reverse 5’-TTTTCTAGAGCCCTCCTCGCTCTGCCGGGC-3’; cry 
KR6, forward 5’-TFTCTGCAGCCGGAGGTGTCCGACCAGCTC-3 
and reverse 5’-TTTTCTAGAGGCCCCCACCGCCGGCGTGACGAG- 
CTCGTC-3’; rapAT4, forward 6’-TTTGGA TCCGTGTTTGTTFTCCCGG- 
GGCAG-3’ and reverse 5’-TTTCTGCAGCCAGTACCGCTGGTGTTG- 
GAA-3’; rapDH/KR4 1171, forward 5’-TTCTGCAGAGCGTGGACCGG- 
GCGGCT and reverse 5’-TTTTCTAGAGTCACCGGTAGAGGCGGCC- 
CT-3’; rapACP4, forward 5’~TTTTCTAGAGTGCAGTGGTTGGCAGCT- 
lTG-3’ and reverse 5’-TTTACTAGTCAGCCCGGCGGCCAGGGCC- 
GT. Restriction sites: CTGCAG, Pstl; TCTAGA, Xbal; GGATCC, BarnHI; 
ACTAGT, Spel. 
Construction of DEBS KR substitution plasmids 
Plasmid pKAO260 is a derivative of pCKl2 [13] in which Psd and Xbal 
restriction sites were engineered identical those previously described 
[lo]. Plasmids pKOSO1 l-54 and pKAO288 were obtained by replac- 
ing the KR2 domain (PsdlXbal fragment) of pKA0260 with the eryKR5 
and eryKR6 cassettes, respectively. 
Construction of plasmids containing intramodular fusions and 
artificially linked DEBS genes 
Plasmids pKAO290, pKAO223, pKA0296, pKAC222, pKAC301, 
pKAO306, pKA0318, and pKAC330 were all constructed as in viva 
deletions of pCK7 [231 using a homologous in viva recombination 
method previously described [23]. To create the fusion junctions PCR 
fragments -1 kb in length and containing the appropriate engineered 
restriction site at the boundary were generated. The two corresponding 
fragments from each side of the junction were ligated together in the 
vector pMAK705 124) used for homologous recombination. DNA 
sequences of the resulting junctions are as follows (engineered 
restriction sites italicized): pKA0290, eryKS2..GCCTCCGACGGTG- 
GATCCGTTllCGTCllC.eryAT6; pKAO223, eryATB..CGCGCAA- 
GCCTGCATATGACCCGCGAGTCG..eryKRG; pKA0296, eryAT3..T- 
CGCGGAGCTGGGTACCGGCGGGCACGGCG..eryKR6; pKAO222, 
eryAT3..AAGCGCTACTGGCTGCAGeCGGAGCCGGAGGTGTCC..eryKR6; 
pKAO301, eryKS3..GTGGACGGGCGCGGATCCGllTTCGTCllC- 
..eryATG; pKA0306, eryACP2..GCCGGllTCCTCACrAG~ACC- 
CGATCGCG..eryKSG. GGATCC, BarnHI; CATATG, Ndel; GGTACC, 
Kpnl, CTGCAG, fsfl; ACTAGT, Spel. The engineered boundaries for 
plasmids pKAO318 and pKA0330 are shown in Figure 5. 
Construction of DEBS/RAPS hybrid plasmids 
Piasmid pKOSOl l-33 is a derivative of pKAO330 (see above) with 
engineered BarnHI, Psd, and Xbal restriction sites. The location of the 
Psfl and Xbal sites are identical to those previously described [lo]. The 
BamHl site resulted in the following altered DNA sequence between 
the DEBS KS2 and AT2 domains: 5’-GCCTCCGACGGTGGATCC- 
GTGTTCGTCTTC-3’ (BarnHI site italicized). The rapAT4, rapDH/KR4, 
and rapACP4 domains were inserted into corresponding sites in 
pKOSO1 l-33 to generate pKOSO1 l-46, pKOSO1 l-47, pKOSO1 l-57, 
pKOSO1 l-58, and pKOSO1 l-59 (see Figure 6). 
Purification and characterization of polyketides 
Each strain was grown on a total of 200-500 ml of R2YE agar on petri 
plates. The purification and characterization of compounds 2 Ill], 3 
[lo], 4 [14], 5 [14], and 6 [17] proceeded as previously described. 
TLC analysis was performed with the previously purified and character- 
ized compounds as controls. ‘H and 13C NMR spectra, recorded at 
400 MHz, were identical to the reported data. 
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